india to allow novavaxs vaccine for trials for kids
Early-stage clinical trial results showed that their vaccine is safe and elicits an immune response for the children. Since this vaccine uses a different technology from the doses already widely licensed around the world, it is more suitable for children. Primarily, it is a protein-based vaccine engineered from the genetic sequence of the first strain of the coronavirus.
India’s drug regulator announced yesterday that they will allow vaccine maker Serum Institute to enroll kids aged 7-11 years for its trial of Novavax’s vaccine. It will be a huge leap for the country to prepare to protect children from the coronavirus. The South Asian nation has already administered more than 870 million doses to adults among its population of nearly 1.4 billion.
An expert from Central Drugs Standard Control Organization mentioned that after detailed deliberation, the committee recommended allowing enrolment of subjects of 7 to 11 years of age group as per the protocol. It can be stored at a temperature between 2 and 8 degrees Celsius. Other vaccine companies including Moderna, Johnson & Johnson, and Pfizer are also conducting trials in adolescents, but India will prefer Novavax’s vaccine for now.
It will be a crucial step for Indian healthcare experts since vaccine authorization for children is seen as a crucial step towards achieving herd immunity.
The UK election results are in and it is not as surprising as the election…
As the Budget approaches taxpayers are eager to see what benefits the Finance Minister might…
Fennel, also referred to as saunf, is a familiar spice among Indian households. It is…
In a powerful statement at the Shanghai Cooperation Organisation (SCO) Council of Heads of State…
After releasing from the jail, Hemant Soren will take oath as the new Chief Minister…
Throughout history, various cultures have crafted statues with their inception beginning at ancient times to…
This website uses cookies.
Read More